Send CathInfo's owner Matthew a gift from his Amazon wish list:https://www.amazon.com/hz/wishlist/ls/25M2B8RERL1UO
0 Members and 1 Guest are viewing this topic.
You (plural) point to the Church teaching about being "sober." THAT is based on the risks of abuse. I see no mention in 1 Thessalonians 5:7-9 of exceptions, so how exactly does the Church justify ANY use of alcohol? Return to first principles: avoid undue risk of self-harm (whether physically or spiritually).Since you claim MJ use is different from alcohol use, the burden is on YOU to make the case for the moral or medical difference—on something more substantial than your half-baked [pun-intended] "opinion."No. I cannot point to "a" single study, but to dozens, even hundreds of studies. Glad you asked. Start here, my bibliography for a series of 8 articles I wrote about medical marijuana in 2010-2011 when it was an issue in our state:Important reviewsUniversity of California Center for Medical Cannabis Research—2010 Report to the Legislaturehttp://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdfReview on clinical studies with cannabis and cannabinoids 2005-2009. Hazecamp A and Grotenhermen F. Cannabinoids 2010;5(special issue):1-21.www.cannabis-med.org/data/pdf/en_2010_01_special.pdfCannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdfEmerging Clinical Applications for Cannabis and Cannabinoids: A Review of the Recent Scientific Literature, 2000 – 2010. Armentano P. NORML Foundation, Washington DC 2010.http://norml.org/pdf_files/NORML_Clinical_Applications_for_Cannabis_and_Cannabinoids.pdfMarijuana and Medicine: Assessing the Science Base. National Academy of Science Institute of Medicine, 1999http://www.nap.edu/openbook.php?record_id=6376popularized in: Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.http://books.nap.edu/openbook.php?record_id=9586&page=R1AIDS/HIVUniversity of California Center for Medical Cannabis Research—2010 Report to the Legislaturehttp://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdfHuman Immunodeficiency Virus (HIV)http://www.norml.org/index.cfm?Group_ID=7485“Marijuana and AIDS” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.http://books.nap.edu/openbook.php?record_id=9586&page=86ALS (Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease)Amyotrophic Lateral Sclerosis (ALS)http://www.norml.org/index.cfm?Group_ID=7004Alzheimer's DiseaseAlzheimer's Diseasehttp://norml.org/index.cfm?Group_ID=7003Cachexia. Wasting syndromeSee sections 3.1 and 3.2 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdfCancerGliomas/Cancerhttp://www.norml.org/index.cfm?Group_ID=7008“Marijuana and Cancer” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.http://books.nap.edu/openbook.php?record_id=9586&page=95Cannabis and Cannabinoids (PDQ®). National Cancer Institute. 2011.http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page1Cardiovascular diseaseThe Potential for Clinical Use of Cannabinoids in Treatmentof Cardiovascular Diseases. Durst R and Lotan C. Cardiovascular Therapeutics 2011 Feb;29(1):17-22. doi: 10.1111/j.1755-5922.2010.00233.x. Epub 2010 Oct 14.http://www.ncbi.nlm.nih.gov/pubmed/20946323The emerging role of the endocannabinoid system in cardiovascular disease. Pacher P, Steffens S. Semin Immunopathol. 2009 Jun;31(1):63-77. Epub 2009 Apr 9.http://www.springerlink.com/content/a04103g160h16450/fulltext.pdfCannabinoid receptors in atherosclerosis. Steffens S, Mach F. Curr Opin Lipidol. 2006 Oct;17(5):519-26.http://journals.lww.com/co-lipidology/Abstract/2006/10000/Cannabinoid_receptors_in_atherosclerosis.5.aspxCannabinoid receptors in acute and chronic complications of atherosclerosis. Mach F, Montecucco F, Steffens S. Br J Pharmacol. 2008 January; 153(2): 290–298.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/pdf/0707517a.pdfEndocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Pacher P, Haskó G. Br J Pharmacol. 2008 Jan;153(2):252-62. Epub 2007 Nov 19.http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0707582/pdfThe role of the endocannabinoid system in atherosclerosis. Mach F, Steffens S. J Neuroendocrinol. 2008 May;20 Suppl 1:53-7.http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01685.x/pdfCardiovascular Effects of Cannabis | Medicinal Cannabis Information. Independent Drug Monitoring Unit, United Kingdom, undatedhttp://www.idmu.co.uk/canncardio.htmCrohns DiseaseGastrointestinal Disordershttp://www.norml.org/index.cfm?Group_ID=7009Endocannabinoid sysytemThe Endocannabinoid System as an Emerging Target of Pharmacotherapy. National Institute of Health: Pacher P, Bátkai S, Kunos G. Pharmacol Rev. 2006 Sep;58(3):389-462.http://pharmrev.aspetjournals.org/content/58/3/389.full.pdfEndocrine disease, diabetesThe emerging role of the endocannabinoid system in endocrine regulation and energy balance. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. Endocr Rev. 2006 Feb;27(1):73-100. Epub 2005 Nov 23.http://fk.uwks.ac.id/elib/Arsip/Departemen/Biokimia/The%20Emerging%20Role%20of%20the%20Endocannabinoid%20System.pdfFibromyalgiaNabilone for the Treatment of Pain in Fibromyalgia. Skrabek RQ, Galimova L, Ethans K, Perry D. J Pain. 2008 Feb;9(2):164-73. Epub 2007 Nov 5.http://docs.google.com/viewer?a=v&q=cache:9gDyCVhqJSMJ:files.meetup.com/404848/2008_Nabilone-for-the-Treatment-of-Pain-in-Fibromyalgia.pdf+Nabilone+for+the+Treatment+of+Pain+in+Fibromyalgia&hl=en&gl=us&pid=bl&srcid=ADGEESjFGavzxEJkBjsOj_YyWPHuo5PRG034PLna8X6n3sXGT696PVuaEH15HF07xVpfV10wLPfon8-nZoD0RcJfU6LInnuqHOGpKDECN4oQ6OWBgGgwXWckH2QB31FTn1BZn0KX9U7A&sig=AHIEtbQlDN8uMzxJIm6KKL0POTJdhmbsvgDelta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Schley M, Legler A, Skopp G, Schmelz M, Konrad C, Rukwied R. Curr Med Res Opin. 2006 Jul;22(7):1269-76.http://www.ncbi.nlm.nih.gov/pubmed/16834825Fibromyalgiahttp://norml.org/index.cfm?Group_ID=7007GlaucomaAmerican Glaucoma Society position statement: Marijuana and the treatment of glaucoma. American Glaucoma Society, Prepared by Henry Jampel, M.D., M.H.S., August 10, 2009http://www.americanglaucomasociety.net/associations/5224/files/Marijuana%20and%20Glaucoma%20august%2030_BOD%20Approved%2010.23.09.pdfMarijuana and Glaucoma” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.http://books.nap.edu/openbook.php?record_id=9586&page=124Hepatitis CHepatitis Chttp://www.norml.org/index.cfm?Group_ID=7010Marijuana effects, drug levels, DUIMarijuana effect and delta9-tetrahydrocannabinol plasma level. Chiang CWN and Barnett G. Clinical Pharmacology and Therapeutics 1984 Aug;36(2):234-8.http://www.ncbi.nlm.nih.gov/pubmed/6086207Contact highs and urinary cannabinoids excretion after passive exposure to marijuana smoke. Cone EJ and Johnson RE. Clinical Pharmacology and Therapeutics 1986 Sep;40(3):247-56.http://www.ncbi.nlm.nih.gov/pubmed/3017628Do delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Pope HG, Herning R, Cadet JL, Huestis MA. Addiction. 2009 Dec;104(12):2041-8. Epub 2009 Oct 5.http://www.clinchem.org/cgi/reprint/49/7/1114Developing limits for driving under cannabis. Grotenhermen F, Leson G, Berghaus G, Drummer OH, Krüger HP, Longo M, Moskowitz H, Perrine B, Ramaekers JG, Smiley A, Tunbridge R. Addiction 2007 Dec;102(12):1910-7. Epub 2007 Oct 4.http://www.ncbi.nlm.nih.gov/pubmed/17916224Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Clin Chem. 2003 Jul;49(7):1114-24.http://www.ncbi.nlm.nih.gov/pubmed/12816908Editorial: Practical Challenges to Positive Drug Tests for Marijuana. ElSohly MA. Clin Chem. 2003 Jul;49(7):1037-8.http://www.clinchem.org/cgi/reprint/49/7/1037Dose related risk of motor vehicle crashes after cannabis use. Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Drug Alcohol Depend. 2004 Feb 7;73(2):109-19.http://www.ukcia.org/research/DoseRelatedRiskOfCrashes.pdfTolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G. Psychopharmacology (Berl). 2011 Mar;214(2):391-401. Epub 2010 Oct 30.http://www.cannabistherapyinstitute.com/bills/dui/raemakers.etal.pdfCannabis and Driving: A Scientific and Rational Review. Armentano P. NORML Foundation, Washington DC 2010http://norml.org/index.cfm?Group_ID=7459Sex differences in the effects of marijuana on simulated driving performance. Anderson BM, Rizzo M, Block RI, Pearlson GD, O'Leary DS. J Psychoactive Drugs. 2010 Mar;42(1):19-30.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033009/Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. Ronen A, Gershon P, Drobiner H, Rabinovich A, Bar-Hamburger R, Mechoulam R, Cassuto Y, Shinar D. Accid Anal Prev. 2008 May;40(3):926-34. Epub 2007 Nov 26.http://www.ncbi.nlm.nih.gov/pubmed/18460360Muscle SpasmsDystoniahttp://www.norml.org/index.cfm?Group_ID=7006“Marijuana and Muscle Spasticity” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.http://books.nap.edu/openbook.php?record_id=9586&page=106NauseaSee sections 3.1 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdfPainUniversity of California Center for Medical Cannabis Research—2010 Report to the Legislaturehttp://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdfChronic Painhttp://www.norml.org/index.cfm?Group_ID=7786“Marijuana and Pain” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.http://books.nap.edu/openbook.php?record_id=9586&page=77#Post traumatic Stress DisorderCannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. Ganon-Elazar E, Akirav I. J Neurosci. 2009 Sep 9;29(36):11078-88.http://www.jneurosci.org/content/29/36/11078.full.pdf+html[Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders]. Lehner M, Wisłowska-Stanek A, Płaznik A. Psychiatr Pol. 2009 Nov-Dec;43(6):639-53.http://www.ncbi.nlm.nih.gov/pubmed/20209877The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD). Fraser GA. CNS Neurosci Ther. 2009 Winter;15(1):84-8.http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2008.00071.x/pdfPublic policyHarm reduction-the cannabis paradox. Melamede R. Harm Reduct J. 2005 Sep 22;2:17.http://www.harmreductionjournal.com/content/pdf/1477-7517-2-17.pdfSeizuresSee sections 3.7 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf“Marijuana and Neurological Disorders” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.http://books.nap.edu/openbook.php?record_id=9586&page=115
I see no mention in 1 Thessalonians 5:7-9 of exceptions, so how exactly does the Church justify ANY use of alcohol?
Since LT has started multiple threads, I’ll post his quote from the other thread. Above is his puritanical extremism where he’s arguing that there’s no proof of the Church allowing moderate alcohol use.
The psalmist literally says "blessed be God who maketh wine to cheer the heart of man." Not God who maketh wine as an anesthetic substitute or who maketh wine for the antioxidants. Drink wine so you feel happier. That's recreational. Come on.
Ditto…I'd argue that it is his disordered pea brain that refuses to comprehend the difference between "drunk" and "partaking."
Yep.Christ, Himself, changed water into wine, for a wedding.
LT asks for proof if the Church condones alcohol …and yet the priest drinks wine everyday at mass.
I wonder what they think of St Augustine? He wrote about his past sins? Was he a pervert and blowhard?
…Most of The fruits of the Catholic Church are not good.…
…heroine…
QuoteI see no mention in 1 Thessalonians 5:7-9 of exceptions, so how exactly does the Church justify ANY use of alcohol?Since LT has started multiple threads, I’ll post his quote from the other thread. Above is his puritanical extremism where he’s arguing that there’s no proof of the Church allowing moderate alcohol use.